2024-10-07 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis

**1. Performance Comparison:**

HCA Healthcare Inc. (HCA) is a for-profit hospital and healthcare system operator. The company's stock has significantly outperformed the S&P 500 (VOO) over the period analyzed. 

* **Cumulative Return (HCA):** 321.43%
* **Cumulative Return (VOO):** 133.14%
* **Divergence:** 188.29% (meaning HCA has outperformed VOO by 188.29% points)
* **Relative Divergence:** 93.43% (meaning HCA's performance is currently in the 93.43rd percentile compared to its historical performance relative to VOO)

**2. Recent Price Movement:**

* **Closing Price:** $394.07
* **5-Day Moving Average:** $400.45
* **20-Day Moving Average:** $398.88
* **60-Day Moving Average:** $374.67

The stock price is currently trading below its 5-day and 20-day moving averages, suggesting potential short-term downward pressure. However, the price remains above the 60-day moving average, indicating longer-term support.

**3. Technical Indicators:**

* **RSI:** 36.53 (Neutral - not in overbought or oversold territory)
* **PPO:** -0.57 (Negative - suggests potential short-term weakness)
* **Delta_Previous_Relative_Divergence:** -3.61 (Negative - indicates short-term bearish momentum)
* **Expected Return:** 0.88% (Represents the potential 5-year expected return, exceeding the S&P 500, VOO)

**4. Recent Earnings and Outlook:**

| Date       | EPS | Revenue       |
|------------|-----|---------------|
| 2024-07-29 | 5.6 | $17.49 Billion |
| 2024-05-02 | 6.01 | $17.34 Billion |
| 2023-10-26 | 3.98 | $16.21 Billion |
| 2023-08-02 | 4.35 | $15.86 Billion |
| 2024-07-29 | 4.35 | $15.86 Billion |

HCA's latest earnings report for the quarter ending July 29, 2024, exceeded analysts' expectations. EPS came in at $5.6, higher than the anticipated $5.44. Revenue also surpassed expectations, reaching $17.49 billion against the anticipated $17.35 billion. This indicates strong performance and positive outlook for the company.

**5. News and Recent Issues:**

Recent market outlooks for HCA are generally positive. Analysts highlight the company's strong market position, continued growth in patient volumes, and efficient operations. The potential for further consolidation in the healthcare industry could benefit HCA as a leader in the space. However, the company faces potential headwinds from rising inflation and labor costs.

**6. Overall Analysis:**

HCA Healthcare Inc. has demonstrated strong performance, outperforming the S&P 500 significantly. While recent technical indicators suggest some short-term weakness, the long-term outlook remains positive due to the company's strong financial performance, consistent earnings growth, and market dominance. The company's positive outlook is reinforced by analyst recommendations and the potential for further growth through acquisitions and expansion.

**7. Summary:**

HCA Healthcare Inc. is a large-cap healthcare company with a strong track record of growth and profitability. The company has outperformed the S&P 500 significantly, and its recent earnings report exceeded expectations. Despite some short-term headwinds, the long-term outlook for HCA remains positive, fueled by its market position, operational efficiency, and growth potential. Investors may consider HCA as a potential long-term holding for its attractive returns and resilient nature within the healthcare sector.

**Note:** This is a general overview and not financial advice. Please consult with a qualified financial professional for personalized investment decisions. 
